NCT07236606 RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06942520 Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME) Status RECRUITING Phase PHASE2
NCT05693142 AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05683379 AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05407636 Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05296447 Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic Retinopathy Status ENROLLING_BY_INVITATION Phase PHASE2
NCT05210803 Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD Status ENROLLING_BY_INVITATION Phase PHASE2
NCT04704921 Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04571970 RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome) Status COMPLETED Phase PHASE1/PHASE2
NCT04567550 RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04514653 RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04148001 Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients Status COMPLETED Phase N/A
NCT04080050 A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501 Status UNKNOWN Phase N/A